DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CarePublication CharacteristicsGeographicals
Clinical Trials, Phase III as TopicClinical Trials as TopicTreatment OutcomeClinical Trials, Phase II as TopicDouble-Blind MethodResearch DesignRandomized Controlled Trials as TopicAntineoplastic Combined Chemotherapy ProtocolsClinical Trials, Phase I as TopicDrug Administration SchedulePlacebosAntineoplastic AgentsControlled Clinical Trials as TopicMulticenter Studies as TopicDisease-Free SurvivalClinical Trials, Phase IV as TopicPatient SelectionTime FactorsSurvival AnalysisCisplatinProspective StudiesNeoplasmsFluorouracilCombined Modality TherapyFollow-Up StudiesQuality of LifeDeoxycytidineLung NeoplasmsEarly Termination of Clinical TrialsSurvival RateEndpoint DeterminationClinical ProtocolsPaclitaxelChemotherapy, AdjuvantSingle-Blind MethodTaxoidsNeoplasm StagingEvidence-Based MedicineInfusions, IntravenousBreast NeoplasmsAntibodies, Monoclonal, HumanizedAdministration, OralDrug Therapy, CombinationClinical Trials Data Monitoring CommitteesUnited StatesDose-Response Relationship, DrugSample SizeDisease ProgressionCarcinoma, Non-Small-Cell LungVinblastineDrugs, InvestigationalKaplan-Meier EstimatePrognosisPeriodicals as TopicCarboplatinCongresses as TopicDoxorubicinMedical OncologyPilot ProjectsNeoplasm MetastasisCyclophosphamideSeverity of Illness IndexLeucovorinAntibodies, MonoclonalCost-Benefit AnalysisAntimetabolites, AntineoplasticGuidelines as TopicQuestionnairesMyoelectric Complex, MigratingRisk FactorsBiomedical ResearchRisk AssessmentOutcome Assessment (Health Care)Treatment FailureColorectal NeoplasmsDrug ApprovalMeta-Analysis as TopicRecurrenceOrganoplatinum CompoundsReview Literature as TopicPractice Guidelines as TopicNauseaResearch SubjectsReproducibility of ResultsEpirubicinProportional Hazards ModelsFeasibility StudiesNeoplasm Recurrence, LocalEuropePatient ComplianceDrug-Related Side Effects and Adverse ReactionsVincristineMethotrexatePatient Education as TopicClinical Trial, Phase IIIAntineoplastic Agents, PhytogenicAbstracting and Indexing as TopicRadiotherapy, AdjuvantNational Cancer Institute (U.S.)Remission Induction